-0.09 | -4.09%
- Netflix: The Biggest Empty Promise Since Enron?
- Why Car Prices Vary From City To City
- Big Bank Phobia: Not Too Big to Fail
- Apple Should Still Fire Tim Cook
- Expect Your Health Care in Retirement to Hit $200,000
|
|
|
|
|
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 2.11 |
| 52 Week High | 4.78 |
| 52 Week Low | 1.90 |
| Avg. Daily Vol. (Mil) | 0.03 |
| Beta (3 year) | -1.32 |
| Share Related Items | |
| Mkt Cap (Mil) | 44.34 |
| Shares Out (Mil) | 21.02 |
| Float (Mil) | 17.86 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 6.20 |
| Current Ratio | 6.70 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 1.97 |
| Price/Book | 2.51 |
| Price/Cash Flow | -25.90 |
| Per Share Data | |
| Earnings | -0.14 |
| Sales | 1.07 |
| Book Value | 0.84 |
| Cash Flow | -0.08 |
| Business Summary | |
|---|---|
| Uroplasty, Inc. is a medical device company that develops, manufactures and markets innovative, proprietary products for the treatment of voiding dysfunctions. | |
| General Information | |
| 5420 Feltl Road
Minnetonka, MN 55343 |
|
| www.uroplasty.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 104 | |
| CEO: Mr. Robert E. Kill | |
| Short Interest | |
| Current Month (Mil) | 0.08 |
| Previous Month (Mil) | 0.08 |
| Short Interest Ratio (Days) | 2.70 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -14.00 |
| Return on Investments | -16.00 |
| Profitability | |
| Gross Margin | 87.90 |
| EBIT Margin | -12.70 |
| Profit Margin | -12.90 |
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
|
|
Brokerage Partners
|
|
|
|
|
|
|
|
Most Commented
Advertising Partners
|
|
|
|
We respect your privacy.